Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Dec;24(6):713–719. doi: 10.1111/j.1365-2125.1987.tb03236.x

Once daily amlodipine in the treatment of mild to moderate hypertension.

J Webster 1, O J Robb 1, T A Jeffers 1, A K Scott 1, J C Petrie 1, H M Towler 1
PMCID: PMC1386394  PMID: 2964253

Abstract

1. The antihypertensive efficacy of once-daily amlodipine was studied in a group of 30 patients with mild to moderate hypertension in a double-blind, placebo controlled parallel group study. The dose range of amlodipine was 2.5-10 mg daily titrated at 2 weekly intervals for a total treatment period of 8 weeks. 2. Amlodipine produced a significant reduction in blood pressure compared with placebo, the mean difference between baseline and 8 weeks (corrected for placebo effect) being 16/12 mm Hg supine, 14/4 mm Hg standing. 3. Blood pressure returned to baseline values during a terminal 4 week washout period on placebo. 4. There were no significant effects on heart rate. 5. Two patients experienced slight ankle oedema while receiving amlodipine 10 mg daily but the active drug was otherwise well tolerated. 6. Plasma concentration of amlodipine, sampled 24 h after the preceding dose, increased as the dose titration sequence was followed, averaging 2.5 ng ml-1 on 2.5 mg, 4.9 ng ml-1 on 5 mg and 10.5 ng ml-1 on 10 mg.

Full text

PDF
716

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Faulkner J. K., McGibney D., Chasseaud L. F., Perry J. L., Taylor I. W. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol. 1986 Jul;22(1):21–25. doi: 10.1111/j.1365-2125.1986.tb02874.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Jeffers T. A., Webster J., Petrie J. C., Barker N. P. Atenolol once-daily in hypertension. Br J Clin Pharmacol. 1977 Oct;4(5):523–527. doi: 10.1111/j.1365-2125.1977.tb00780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Pitlik S., Manor R. S., Lipshitz I., Perry G., Rosenfeld J. Transient retinal ischaemia induced by nifedipine. Br Med J (Clin Res Ed) 1983 Dec 17;287(6408):1845–1846. doi: 10.1136/bmj.287.6408.1845-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Sorkin E. M., Clissold S. P., Brogden R. N. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs. 1985 Sep;30(3):182–274. doi: 10.2165/00003495-198530030-00002. [DOI] [PubMed] [Google Scholar]
  5. Webster J., Newnham D., Robb O. J., Petrie J. C. Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazide. Br J Clin Pharmacol. 1987 Feb;23(2):151–157. doi: 10.1111/j.1365-2125.1987.tb03023.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES